Pall Medical continues to advance healthcare safety through innovative filtration solutions designed to protect patients and healthcare professionals from contamination risks. For more than 75 years, the company has set global standards for safety, purity, and technological excellence in clinical environments.
Since 2023, Pall Medical has operated as a market brand within Cytiva, part of Danaher—a global leader in life sciences and diagnostics. By leveraging Cytiva’s global expertise while maintaining a deep specialization in medical filtration, Pall Medical currently serves healthcare facilities across 30 countries through 80 locations, supported by a team of 200 dedicated associates.
Comprehensive Product Portfolio and Membrane Technologies
Pall Medical offers a broad range of solutions tailored to meet the stringent requirements of medical device manufacturers and healthcare providers:
- Medical OEM Devices: Featured products include IV-3 and IV-6 in-line filters, 25mm Acrylic Liquid and Gas Filters, Intervene™ infusion filters, and Gardian100™ for advanced contamination control.
- Membrane Technologies: High-performance options include Versapor™ RC membranes for reliable filtration, Pallflex™ for specialty applications, PTFE for chemical resistance, and Supor™ membranes for sterilizing-grade filtration.
Expert Services and Clinical Support
Beyond hardware, Pall Medical provides critical technical support to ensure optimal performance and patient safety:
- Clinical Specialist Team: Provides hands-on support for OEM integration and product implementation.
- Scientific Laboratory Services (SLS): Conducts drug binding studies, simulated infusion tests, and forensic analysis
A Legacy of Innovation
The company’s history is rooted in groundbreaking achievements, from Dr. David Pall’s invention of porous stainless steel in 1946 to developing filters used in NASA’s Lunar Module. Pall Medical remains driven by the belief that modern patients deserve the same level of protection that enabled these historic milestones.
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With nearly 16 000 associates in more than 40 countries, we're driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers. Learn more at cytiva.com/pallmedical
